PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration for Targeted Alpha Therapy Candidate VISN Q1 2026 Earnings EPS Surges 709 Above Estimates Shares Edge Lower Kazatomprom Reports 17 Production Surge in Third Quarter